Novo Nordisk has reported sales increases over the first half of 2017, despite drug pricing concerns. Sales of specific Novo Nordisk pharmaceuticals rose into the triple digit percentile, encouraging the company to re-analyze its 2017 profit margin figures. The company has touted a strong portfolio as the main source of financial success in the first half of this year. Read the full press release here.